Cell avidity-tuning ensures safe CAR-T therapy for solid tumors
Learn more about the potential of cell avidity in designing potent and safe CAR-T treatments for solid tumors.
- Latest Posts
In Depth 13 May 2024
New antidepressants: tackling treatment resistant depression
Take a look at how new antidepressants can more effectively tackle treatment resistant depression compared to more traditional treatments.
Expert Advice 10 May 2024
How to prepare for an interview at a biotech company
Find out how to best prepare yourself for biotech interview questions after applying for a job at a company.
Podcast 10 May 2024
Cytokinetics’ cardiovascular pipeline beats strong
Discover Cytokinetics’ groundbreaking cardiovascular treatments, including heart drug aficamten, in our latest podcast with CEO Robert Blum.
In Depth 9 May 2024
BTK inhibitors: can these drugs tackle cancer and autoimmunity?
BTK inhibitors were first approved over a decade ago to treat a rare blood cancer. Now, they are in the running to treat a host of autoimmune diseases.
In Depth 9 May 2024
The biggest private biotech investments in April 2024
The companies Xaira Therapeutics, Metsera, and Obsidian Therapeutics bagged the biggest private biotech investments in April 2024.
ADVERTISEMENT
ADVERTISEMENT
In Depth 8 May 2024
New treatment for pulmonary hypertension: what biotech holds in store?
While it has been about managing pulmonary hypertension’s symptoms for a long time, new treatments are adressing the root of the disease.
Best in Biotech 7 May 2024
Biotech in New Jersey: Nine companies leading the charge
Delve into one of the most dynamic biotech region in the U.S. and discover nine New-Jersey-based companies to put on your radar.
In Depth 6 May 2024
The rise of Spain: A key player in global clinical trials
Spain has climbed the research and development ladder in recent years, and has made it to the top as one of the world leaders in the life science industry.
In Depth 3 May 2024
Can emerging new treatments lead the way to cure Duchenne muscular dystrophy?
Delve into the new treatment approaches to Duchenne muscular dystrophy, a challenging disease for those suffering from it, and research.
In Depth 2 May 2024
New treatments for cystic fibrosis: boosting life expectancy
Discover how cystic fibrosis treatments are extending life expectancy, with recent advancements set to increase it by 75% by next year.
Best in Biotech 2 May 2024
Eight monoclonal antibody biotechs making strides in the clinic
In this article, we take a look at eight biotechs advancing their monoclonal antibodies through the clinic that have made the news in recent times.
ADVERTISEMENT
